Longevity Health Holdings, Inc.

XAGE OTC CIK: 0001842939

Company Information

Industry Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
SIC Code 2840
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 2403 SIDNEY STREET, SUITE 300, PITTSBURGH, PA, 15203
Mailing Address 2403 SIDNEY STREET, SUITE 300, PITTSBURGH, PA, 15203
Phone 412-894-8248
Fiscal Year End 1231
EIN 861645738

Financial Overview

FY2025

$2.37M
Total Assets

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 17, 2026 View on SEC
8-K Current report of material events December 12, 2025 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
8-K Current report of material events November 7, 2025 View on SEC
8-K Current report of material events September 12, 2025 View on SEC
10-Q Quarterly financial report August 14, 2025 View on SEC
8-K Current report of material events July 14, 2025 View on SEC
8-K Current report of material events June 25, 2025 View on SEC
10-K/A Annual report amendment June 17, 2025 View on SEC

Annual Reports

10-K March 31, 2026
  • Successful pivot to bio-aesthetics with the Elevai skincare line as the primary revenue driver.
  • Transition from research-heavy operations to a direct-to-consumer and professional product-sales model.
View Analysis

Material Events

8-K Financial Distress March 17, 2026
High Impact
  • Longevity Health secured a $200,000 capital infusion through a private placement.
  • New CEO and Chairman, Janakiram Ajjarapu, appointed, signaling a fresh strategic direction directly linked to the new investor.
View Analysis

Related Companies

Companies in the same industry (SIC: 2840)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.